The Rev. Jesse Jackson disclosed publicly Friday that he has been seeking outpatient care for two years for Parkinson's disease. » Read More
By: Meg Tirrell
Steve Pete and Reid Millius, with mirror-image genetic mutations, are helping companies develop better pain medicines. » Read More
By: Dan Mangan
Obamacare is seen favorably by 50 percent of Americans, and unfavorably by 46 percent, according to a Kaiser Family Foundation poll. » Read More
Tesla CEO Elon Musk unveiled the Tesla Semi truck on Thursday.
The condition of North Korea's latest escapee revealed worrying insights about health and hygiene in the rogue state.
Jim Cramer said the old-school tech company could be ready to make a comeback, despite the moves of Warren Buffett.
Jim Cramer sat down with Dexcom President and CEO Kevin Sayer, who said Abbott's glucose monitoring products have "nothing" on Dexcom's.
Jim Cramer zoomed in on the track record of Abbott CEO Miles White, who has transformed the company since he took over in 1999.
Goldman Sachs reiterates its buy rating for Intuitive Surgical shares, predicting the company will report earnings above expectations next year.
Senate Republicans want to kill Obamacare's individual mandate to free up almost $340 billion in federal spending.
Years of careful planning can go up in smoke if you have an unexpected accident or illness. How to avoid that.
Express Scripts, the largest pharmacy benefits manager, is teaming up with a start-up that specializes in COPD and asthma.
Thirty-six percent of elderly Americans reported having three or more chronic health conditions, much higher than other wealthy countries.
Thus far, the service has only launched at a single gym in Australia.
Senate Republicans, as part of a tax bill, have called for ending the requirement that most people have health coverage or pay a fine.
A lawsuit against the Trump administration alleges that some mailed-in DACA applications were spuriously marked late, Vox reports.
GOP's ACA tax plan seems like a good deal for average folks, until they get sick, says Consultant Robert Laszewski.
Obamacare advocates have feared that Trump administration hostility to the insurance program would dampen enrollment this year.
The drugmaker said it paused enrolling patients in two Parkinson's drug trials following patient deaths.
Get the best of CNBC in your inbox